Peter Heerma - 31 Jan 2026 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role: CHIEF COMMERCIAL OFFICER
Signature: /s/ Elizabeth E. Reed, Attorney-in-Fact
Issuer symbol: TVTX
Transactions as of: 31 Jan 2026
Net transactions value: -$234,797
Form type: 4
Filing time: 03 Feb 2026, 21:30:10 UTC
Previous filing: 29 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Heerma Peter	CHIEF COMMERCIAL OFFICER	C/O TRAVERE THERAPEUTICS, INC., 3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO	/s/ Elizabeth E. Reed, Attorney-in-Fact	03 Feb 2026	0001789617

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TVTX	Common Stock	Award	$0	+26,120	+23%	$0.000000	139,133	31 Jan 2026	Direct	F1
transaction	TVTX	Common Stock	Sale	$234,797	-7,310	-5.3%	$32.12	131,823	03 Feb 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TVTX	Employee stock option (right to buy)	Award	$0	+69,640		$0.000000	69,640	31 Jan 2026	Common Stock	69,640	$33.10	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer.
F2	Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
F3	One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.